TerminatedNot Applicable

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

United States9 participantsStarted 2008-08

Plain-language summary

RATIONALE: Studying samples of blood in the laboratory from patients with cancer may help doctors learn more about nausea and vomiting caused by cancer treatment. PURPOSE: This laboratory study is looking at blood samples from patients with cancer who were treated on a clinical trial to control nausea and vomiting during donor stem cell transplant.

Who can participate

Age range18 Years – 120 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Previously collected serum samples from patients with cancer enrolled on the placebo arm of the pilot aprepitant study * Patients treated with busulfan/cyclophosphamide or cyclophosphamide/total body irradiation conditioning regimens prior to undergoing allogeneic hematopoietic stem cell transplantation PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics

What they're measuring

Average, median, and mode for substance P levels at different times

Trial details

NCT IDNCT00900068

SponsorOHSU Knight Cancer Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2009-08

View on ClinicalTrials.gov More Breast Cancer trials